===== DISCHARGE NOTE =====
note_id=12328821-DS-13 | hadm_id=22091494

 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
Cephalosporins / Erythrocin / esomeprazole / Macrolide 
Antibiotics / Penicillins / Sulfa (Sulfonamide Antibiotics)
 
Attending: ___.
 
Chief Complaint:
Abdominal Pain
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Ms. ___ is a ___ with h/o dementia who presents from nursing 
home w/ increased AMS and abdominal pain in the setting of 
recently treated UTI. Briefly, pt was noted to display worsening 
AMS and lethargy along with mild fevers, decreased PO intake, 
and increasing abdominal pain yesterday AM. Notably she was 
recently
treated for symptomatic UTI  (abx and course unknown), though 
she currently reports resolution of sx. She was sent to ___ ED 
for further evaluation where CT A/P showed c/f ischemic vs 
infectious colitis. On arrival, pt was hemodynamically stable 
and labs were notable for a leukocytosis to 15. Her history is 
somewhat unreliable given dementia, but she denies 
fevers/chills, N/V/D, CP/SOB, recurrent dysuria.
 
Past Medical History:
Nonruptured cerebral aneurysm
Hx upper GI bleed
Rotator cuff injury
Fibromyalgia
Urinary incontinence
IDDM type 2- denies insulin or FSBS at home
Hypercholesterolemia
Cataract
Glaucoma
Prior note says hx COPD but pt denies
 
Social History:
___
Family History:
Non-contributory
 
Physical Exam:
Admission Physical Exam:
Vitals:  101.2  101  117/61 19 97% RA          
Gen: A&Ox3 with questioning of person/place/time; well-appearing
female, in NAD
HEENT: No scleral icterus, no palpable LAD
Pulm: CTAB, no w/r/r
CV: NRRR, no m/r/g
Abd: soft, ND focal tenderness to palpation only of LLQ with 
mild
voluntary guarding; no rebound/guarding, no palpable masses
Ext: WWP bilaterally, no c/c/e, no ulcerations
Neuro: moves all limbs spontaneously, no focal deficits

Discharge Physical Exam:
VS:
GEN: Awake, alert, sitting up in bed.
HEENT: PERRL, EOMI. neck midline. Mucus membranes pink/moist.
CV: RRR
PULM: Clear to auscultation bilaterally.
ABD: Soft, non-tender, non-distended. Active bowel sounds.
EXT: Warm and dry. 2+ ___ pulses. No edema.
NEURO: Alert, interactive, oriented x2. Follows commands and 
moves all extremities equal and strong. 

 
Pertinent Results:
___ 06:31AM BLOOD WBC-8.3 RBC-3.89* Hgb-10.1* Hct-32.8* 
MCV-84 MCH-26.0 MCHC-30.8* RDW-15.4 RDWSD-47.5* Plt ___
___ 07:10AM BLOOD WBC-6.4 RBC-3.65* Hgb-9.5* Hct-31.0* 
MCV-85 MCH-26.0 MCHC-30.6* RDW-15.5 RDWSD-48.3* Plt ___
___ 01:45PM BLOOD WBC-6.6 RBC-3.44* Hgb-8.9* Hct-29.3* 
MCV-85 MCH-25.9* MCHC-30.4* RDW-15.5 RDWSD-48.2* Plt ___
___ 07:05AM BLOOD WBC-5.1 RBC-3.73* Hgb-9.7* Hct-32.1* 
MCV-86 MCH-26.0 MCHC-30.2* RDW-15.5 RDWSD-48.8* Plt ___
___ 07:25AM BLOOD WBC-6.9 RBC-3.67* Hgb-9.4* Hct-31.7* 
MCV-86 MCH-25.6* MCHC-29.7* RDW-15.8* RDWSD-50.2* Plt ___
___ 08:20AM BLOOD WBC-8.4 RBC-3.59* Hgb-9.4* Hct-30.3* 
MCV-84 MCH-26.2 MCHC-31.0* RDW-16.1* RDWSD-49.1* Plt ___
___ 02:40PM BLOOD WBC-15.0* RBC-4.09 Hgb-10.7* Hct-34.7 
MCV-85 MCH-26.2 MCHC-30.8* RDW-16.0* RDWSD-50.0* Plt ___
___ 06:31AM BLOOD Glucose-97 UreaN-3* Creat-0.6 Na-138 
K-3.8 Cl-103 HCO3-23 AnGap-12
___ 07:10AM BLOOD Glucose-91 UreaN-3* Creat-0.6 Na-140 
K-3.6 Cl-103 HCO3-23 AnGap-18
___ 01:45PM BLOOD Glucose-95 UreaN-<3* Creat-0.6 Na-137 
K-3.5 Cl-102 HCO3-22 AnGap-17
___ 07:25AM BLOOD Glucose-74 UreaN-10 Creat-0.6 Na-139 
K-3.5 Cl-104 HCO3-20* AnGap-19
___ 03:55PM BLOOD Glucose-111* UreaN-10 Creat-0.7 Na-140 
K-4.5 Cl-105 HCO3-19* AnGap-21*
___ 08:20AM BLOOD Glucose-124* UreaN-8 Creat-0.6 Na-136 
K-2.9* Cl-99 HCO3-20* AnGap-20
___ 02:40PM BLOOD Glucose-154* UreaN-5* Creat-0.7 Na-139 
K-3.4 Cl-99 HCO3-22 AnGap-21*
___ 02:40PM BLOOD cTropnT-<0.01
___ 06:31AM BLOOD Calcium-9.1 Phos-3.4 Mg-1.7
___ 07:10AM BLOOD Calcium-8.8 Phos-3.4 Mg-1.9
___ 07:05AM BLOOD Calcium-8.4 Phos-1.7* Mg-2.0
___ 07:25AM BLOOD Calcium-8.6 Phos-2.8 Mg-1.9
___ 08:20AM BLOOD Calcium-8.8 Phos-1.9* Mg-1.6
___ 02:40PM BLOOD Calcium-9.3 Phos-2.8 Mg-1.9
___ 02:42PM BLOOD Lactate-1.7
___ 02:50PM URINE Blood-NEG Nitrite-NEG Protein-TR* 
Glucose-NEG Ketone-40* Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-NEG
___ 02:50PM URINE Color-Yellow Appear-Clear Sp ___
___ 02:50PM URINE RBC-0 WBC-1 Bacteri-NONE Yeast-NONE Epi-0

___ 4:40 am STOOL     CONSISTENCY: NOT APPLICABLE
      Source: Stool. 
                            **FINAL REPORT ___
   C. difficile DNA amplification assay (Final ___: 
      Reported to and read back by ___ (___) AT 12:50 ___ 
___. 
      CLOSTRIDIUM DIFFICILE. 
         Positive for toxigenic C difficile by the Cepheid 
nucleic
         amplification assay.            (Reference 
Range-Negative). 

___ 2:40 pm BLOOD CULTURE
                            **FINAL REPORT ___
   Blood Culture, Routine (Final ___:    NO GROWTH. 

___ 2:50 pm URINE
                            **FINAL REPORT ___
   URINE CULTURE (Final ___:    NO GROWTH.

 
Brief Hospital Course:
Ms. ___ is a ___ yo F with dementia who presented to the 
emergency department from nursing home facility with increased 
confusion, decreased PO intake, and abdominal pain. CT abdomen 
pelvis showed mild pancolitis, which may be infectious, 
inflammatory or ischemic in nature. White blood cell count 8.4. 
Stool sample sent positive for Clostridium Difficile. Blood and 
urine cultures were negative. Chest xray showed no signs of 
pneumonia. She was admitted to the surgical floor for IV fluids, 
abdominal exams, and antibiotic treatment. 

On HD2, abdominal pain decreased and diet was advanced to 
clears. On HD3 her diet was advanced to regular with continued 
good tolerability. On HD4 flagyl was added to antibiotic regimen 
due to continued multiple bowel movements. On HD5 frequency of 
bowel movements decreased, she continued to tolerate a regular 
diet without abdominal pain. White blood cell count was 
monitored and remained stable, within normal limits and the 
patient remained afebrile. The patient voided without problem. 
During this hospitalization, the patient ambulated early and 
frequently, was adherent with respiratory toilet and incentive 
spirometry, and actively participated in the plan of care. The 
patient received subcutaneous heparin and venodyne boots were 
used during this stay.

At the time of discharge, the patient was doing well, afebrile 
with stable vital signs.  The patient was tolerating a regular 
diet, ambulating, voiding without assistance, and pain was well 
controlled.  The patient was discharged to rehab. The patient 
received discharge teaching and follow-up instructions with 
understanding verbalized and agreement with the discharge plan. 

 
Medications on Admission:
ASA 81', atorvastatin 10', brimonidone eye drops b/l eyes ',
buproprion 100'', colace 200'', ferrous sulfate 325', 
latanoprost
b/l eyes QHS, ranitidine 150'', timolol ftt b/l eyes', vesicare
10, vitamin D 2000U', acetaminophen 650'''' PRN, trazodone 25'
PRN insomnia
 
Discharge Medications:
1.  Acetaminophen 1000 mg PO Q6H:PRN Pain - Mild  
2.  MetroNIDAZOLE 500 mg PO Q8H 
End ___.  
3.  Vancomycin Oral Liquid ___ mg PO Q6H 
End ___.  
4.  Aspirin 81 mg PO DAILY  
5.  Atorvastatin 10 mg PO QPM  
6.  Brimonidine Tartrate 0.15% Ophth. 1 DROP BOTH EYES QHS  
7.  BuPROPion 100 mg PO BID  
8.  Ferrous Sulfate 325 mg PO DAILY  
9.  Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS  
10.  Ranitidine 150 mg PO BID  
11.  Timolol Maleate 0.25% 1 DROP BOTH EYES DAILY  
12.  TraZODone 25 mg PO QHS:PRN insomnia  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Clostridium Difficile colitis 

 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Ms. ___,

You were admitted to the Acute Care Surgery Service on ___ 
with abdominal pain and found to have an infection in your lower 
intestine called c.diff. You were given the appropriate 
antibiotics for this infection and your abdominal pain resolved. 
You are now doing better, tolerating a regular diet, and ready 
to be discharged back to rehab to continue your recovery.

Please note the following discharge instructions:

Please call your doctor or nurse practitioner or return to the 
Emergency Department for any of the following:
*You experience new chest pain, pressure, squeezing or 
tightness.
*New or worsening cough, shortness of breath, or wheeze.
*If you are vomiting and cannot keep down fluids or your 
medications.
*You are getting dehydrated due to continued vomiting, diarrhea, 
or other reasons. Signs of dehydration include dry mouth, rapid 
heartbeat, or feeling dizzy or faint when standing.
*You see blood or dark/black material when you vomit or have a 
bowel movement.
*You experience burning when you urinate, have blood in your 
urine, or experience a discharge.
*Your pain in not improving within ___ hours or is not gone 
within 24 hours. Call or return immediately if your pain is 
getting worse or changes location or moving to your chest or 
back.
*You have shaking chills, or fever greater than 101.5 degrees 
Fahrenheit or 38 degrees Celsius.
*Any change in your symptoms, or any new symptoms that concern 
you.

Please resume all regular home medications, unless specifically 
advised not to take a particular medication. Also, please take 
any new medications as prescribed.

Please get plenty of rest, continue to ambulate several times 
per day, and drink adequate amounts of fluids. Avoid lifting 
weights greater than ___ lbs until you follow-up with your 
surgeon.

 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=12328821-DS-12 | hadm_id=23392763

 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Cephalosporins / Erythrocin / esomeprazole / Macrolide 
Antibiotics / Penicillins / Sulfa (Sulfonamide Antibiotics)
 
Attending: ___.
 
Chief Complaint:
parotiditis
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
Ms. ___ is a ___ F w/PMHx significant for IDDM type 2, 
hypercholesterolemia, fibromyalgia, hx of meningitis, presenting 
to our ED with increasing facial swelling and hoarseness. 
Patient has had facial swelling since ___. She was seen at 
an OSH x 2 and given Benadryl for what was assumed to be an 
allergic reaction. She was then sent back to her living 
facility. Since then the swelling, redness, and pain has 
increased, which prompted her facility to bring her to our ED 
___ where she was admitted to the TSICU for airway watch.
 
Past Medical History:
Nonruptured cerebral aneurysm
Hx upper GI bleed
Rotator cuff injury
Fibromyalgia
Urinary incontinence
IDDM type 2- denies insulin or FSBS at home
Hypercholesterolemia
Cataract
Glaucoma
Prior note says hx COPD but pt denies
 
Social History:
___
Family History:
Non-contributory
 
Physical Exam:
ADMISSION EXAM

Gen: sitting up, agitated, short of breath, visibly 
uncomfortable
HEENT: left cheek and neck warm swollen and tender to palpation, 
with redness extending down towards shoulder and up around 
orbit. Minimal mouth opening due to pain. PERRLA, EOMI
Pulm: lungs CTAB, no wheezes/rhonchi appreciated. Distant breath 
sounds likely ___ body habitus
Abd: soft, NT, ND
Ext: WWP
Skin: Skin ok other than redness as described above
Neuro: A&O x 3

DISCHARGE EXAM
98.3 118 / 67 71 18 91 Ra  
General: No apparent distress
HEENT: Minimal left sided facial edema and erythema, almost 
resolved,. Clear oropharynx with minimal swelling. No 
respiratory difficulty.
Cardiac: RRR nl s1/s2
Respiratory: CTAB, no increased effort of respirations
Abdomen: Soft, nontender, nondistended
Extremities: wwp no edema
 
Pertinent Results:
ADMISSION LABS
================
___ 01:00PM BLOOD WBC-20.0* RBC-3.97 Hgb-10.7* Hct-34.1 
MCV-86 MCH-27.0 MCHC-31.4* RDW-16.0* RDWSD-50.3* Plt ___
___ 03:39AM BLOOD WBC-14.3* RBC-3.22* Hgb-8.8* Hct-28.3* 
MCV-88 MCH-27.3 MCHC-31.1* RDW-16.5* RDWSD-52.7* Plt ___
___ 01:00PM BLOOD Neuts-90.1* Lymphs-3.4* Monos-5.0 
Eos-0.1* Baso-0.3 Im ___ AbsNeut-18.01* AbsLymp-0.67* 
AbsMono-0.99* AbsEos-0.01* AbsBaso-0.05
___ 04:53PM BLOOD ___ PTT-24.9* ___
___ 03:39AM BLOOD Plt ___
___ 04:53PM BLOOD ___
___ 01:00PM BLOOD Glucose-196* UreaN-9 Creat-0.7 Na-138 
K-3.9 Cl-97 HCO3-26 AnGap-19
___ 03:39AM BLOOD Glucose-264* UreaN-15 Creat-0.6 Na-137 
K-3.7 Cl-102 HCO3-26 AnGap-13
___ 04:53PM BLOOD ALT-16 AST-26 LD(___)-591* AlkPhos-79 
Amylase-304* TotBili-0.5
___ 03:39AM BLOOD Calcium-8.1* Phos-2.0* Mg-2.4
___ 04:53PM BLOOD calTIBC-225* Ferritn-341* TRF-173*
___ 01:00PM BLOOD %HbA1c-6.0 eAG-126
___ 12:31AM BLOOD ___ pO2-81* pCO2-41 pH-7.42 
calTCO2-28 Base XS-1
___ 01:27PM BLOOD Lactate-1.9
___ 12:31AM BLOOD freeCa-1.08*

DISCHARGE LABS
=================

___ 06:00AM BLOOD WBC-12.7* RBC-3.40* Hgb-9.2* Hct-29.5* 
MCV-87 MCH-27.1 MCHC-31.2* RDW-16.4* RDWSD-51.6* Plt ___
___ 06:00AM BLOOD Plt ___
___ 06:00AM BLOOD Glucose-164* UreaN-19 Creat-0.6 Na-140 
K-4.3 Cl-104 HCO3-22 AnGap-18
___ 06:00AM BLOOD Calcium-8.2* Phos-2.3*

MICROBIOLOGY
===============
No growth on cultures
___ BLOOD CULTURE Blood Culture, Routine-PENDING 
INPATIENT 
___ BLOOD CULTURE Blood Culture, Routine-PENDING 
EMERGENCY WARD 

IMAGING
============

IMAGING: 
CT Neck ___: Findings concerning for acute bacterial parotitis 
with significant adjacent superficial edema and retropharyngeal 
edema.  Enlargement of the left masseter and submandibular gland 
likely reactive. 

 
Brief Hospital Course:
SUMMARY: ___ h/o DM2, HTN, HLD who presents with parotitis, 
initially in ICU for airway monitoring. Was treated with 
dexamethasone and clindamycin. Swelling improved significantly 
and patient was discharged to rehab on PO clindamycin for 
further care.

# Parotitis: Patient presented with new left-sided facial edema 
and swelling. CT Neck on ___ was consistent with acute bacterial 
parotitis with significant edema, without abscess or stone. ENT 
was consulted and recommended conservative treatment with airway 
monitoring in the ICU. She was treated with IV clindamycin 
starting on ___ plus IV dexamethasone for 36 hours, and 
transitioned to PO clindamycin on ___. She was given sialgogues, 
massages, and warm compresses with significant improvement in 
swelling. Never required intubation or developed acute 
respiratory distress. She was evaluated by speech and swallow 
team and was tolerating regular diet without issues. She will 
follow up with ENT in clinic.

CHRONIC ISSUES:
# DMII: Continued insulin sliding scale
# Anemia: Continued ferrous sulfate
# Depression: Continued home bupropion
# Primary prevention: Continued home ASA 81mg, atorvastatin 10mg 
daily
# Glaucoma: Continued home eye drops.
# Urinary incontinence: Vesicare held as not on formulary. 

TRANSITIONAL ISSUES:
- Complete 14-day course of clindamycin (last day ___
- Will follow up with ENT in clinic
- Please monitor closely for signs of aspiration. Patient had a 
small RLL infiltrate but no clinical signs of pneumonia and was 
swallowing without issues. 
- Patient had nocturnal desaturations on telemetry. Please 
consider OSA evaluation as outpatient. 
- PO prednisone discontinued as no longer needed
# Code status: DNR/DNI 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Brimonidine Tartrate 0.15% Ophth. 1 DROP BOTH EYES DAILY 
2. Aspirin 81 mg PO DAILY 
3. Timolol Maleate 0.5% 1 DROP BOTH EYES BID 
4. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS 
5. PrednisoLONE Acetate 1% Ophth. Susp. 1 DROP LEFT EYE QID 
6. PrednisoLONE Acetate 1% Ophth. Susp. 1 DROP RIGHT EYE DAILY 
7. PredniSONE 7 mg PO DAILY 
8. Senna 17.2 mg PO BID:PRN constipation 
9. Vitamin D 1000 UNIT PO DAILY 
10. solifenacin 10 mg oral DAILY 
11. melatonin 5 mg oral QHS 
12. BuPROPion 100 mg PO BID 
13. Ferrous Sulfate 325 mg PO DAILY 
14. Atorvastatin 10 mg PO QPM 
15. Glargine 10 Units Bedtime
16. HYDROcodone-Acetaminophen (5mg-325mg) 1 TAB PO Q8H:PRN Pain 
- Moderate 
17. Polyethylene Glycol 17 g PO DAILY:PRN constipation 
18. EPINEPHrine (EpiPEN) 0.3 mg IM PRN anaphylaxis 
19. Aluminum-Magnesium Hydrox.-Simethicone ___ mL PO QID:PRN 
dyspepsia 
20. Bisacodyl 10 mg PR QHS:PRN constipation 
21. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 
22. TraZODone 25 mg PO QHS:PRN insomnia 
23. Naloxone 0.4 mg Subcut PRN sedation, respiratory depression 

 
Discharge Medications:
1.  Clindamycin 450 mg PO Q6H 
last day ___.  Ipratropium-Albuterol Neb 1 NEB NEB Q6H:PRN shortness of 
breath, wheezing  
3.  Glargine 10 Units Bedtime 
4.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild  
5.  Aluminum-Magnesium Hydrox.-Simethicone ___ mL PO QID:PRN 
dyspepsia  
6.  Aspirin 81 mg PO DAILY  
7.  Atorvastatin 10 mg PO QPM  
8.  Bisacodyl 10 mg PR QHS:PRN constipation  
9.  Brimonidine Tartrate 0.15% Ophth. 1 DROP BOTH EYES DAILY  
10.  BuPROPion 100 mg PO BID  
11.  EPINEPHrine (EpiPEN) 0.3 mg IM PRN anaphylaxis  
12.  Ferrous Sulfate 325 mg PO DAILY  
13.  HYDROcodone-Acetaminophen (5mg-325mg) 1 TAB PO Q8H:PRN Pain 
- Moderate  
14.  Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS  
15.  melatonin 5 mg oral QHS  
16.  Naloxone 0.4 mg Subcut PRN sedation, respiratory depression 
 
17.  Polyethylene Glycol 17 g PO DAILY:PRN constipation  
18.  PrednisoLONE Acetate 1% Ophth. Susp. 1 DROP LEFT EYE QID  
19.  PrednisoLONE Acetate 1% Ophth. Susp. 1 DROP RIGHT EYE DAILY 
 
20.  Senna 17.2 mg PO BID:PRN constipation  
21.  solifenacin 10 mg oral DAILY  
22.  Timolol Maleate 0.5% 1 DROP BOTH EYES BID  
23.  TraZODone 25 mg PO QHS:PRN insomnia  
24.  Vitamin D 1000 UNIT PO DAILY  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS:
Parotitis

SECONDARY DIAGNOSIS:
Hyperlipidemia
Diabetes mellitus, type II
Arthritis

 
Discharge Condition:
Mental Status: Clear and coherent.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).
Level of Consciousness: Alert and interactive.

 
Discharge Instructions:
Dear Ms. ___,

You were admitted to ___ due to facial swelling. We found that 
you had an infection of your glands called parotitis. You were 
admitted to the ICU and given steroids and antibiotics. You 
quickly improved.

You will complete a course of antibiotics at ___ and ___ 
have a follow up appointment with our Ear, Nose, and Throat 
doctors.

___ wish you all the best!
- Your ___ care team
 
Followup Instructions:
___
